Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Leukemia 2Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Ovarian Neoplasms 1Osteoporosis 1Obesity 1Myelodysplastic Syndromes 1Lymphoma 1Breast Neoplasms 1Arthralgia 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Calcium 6Letrozole 4Cholecalciferol 4Calcium Carbonate 4Alendronate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Estradiol 2Denosumab 2Calcium Gluconate 2Aromatase Inhibitors 2Absorptiometry, Photon 2xian ling gu bao 1romosozumab 1X-Rays 1Technetium 1Raloxifene Hydrochloride 1Progesterone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Lysine Acetyltransferase 5 1Ibandronic Acid 1Hormone Replacement Therapy 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteoporosis × Calcium Citrate × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡